The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
批准号:
10705933
负责人:
CYNTHIA A GERHARDT
金额:
$562.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-22 至 2030-07-31
关键词:
AddressAdoptedAppalachian RegionApplied ResearchCOVID-19ClinicalClinical ResearchClinical SciencesClinical and Translational Science AwardsCollaborationsCommunitiesDataData ScienceData SetDecision MakingDemocracyDevelopmentDisciplineDisparityDissemination and ImplementationEducationEffectivenessEnsureEnvironmentEquityFacultyFoundationsFundingGrantGrowthHealthHealthcareHumanIndividualIndustryInfantInfrastructureInstitutionInvestmentsKnowledgeLeadershipLeftLife Cycle StagesMaternal MortalityMedical centerMethodsOhioOutcomes ResearchPatientsPediatric HospitalsPopulationProcessPublic HealthRacial injusticeReach, Effectiveness, Adoption, Implementation, and MaintenanceResearchResearch DesignResearch PersonnelResource InformaticsResourcesRuralScienceSystemSystems IntegrationThinkingTrainingTraining SupportTraining and EducationTranslational ResearchUniversitiesValidationVisionVoiceWorkcareer developmentclinical centerclinical translationclinically relevantcollegecommunity engaged researchcomplex datacomputing resourcescostdata accessdemographicshealth care deliveryhealth disparityhealth equityimplementation scienceimprovedinnovationlensmembermulti-site trialnovel strategiesopioid epidemicresponseskillssocialsocial health determinantstooltranslational pipeline
中文摘要
提取
俄亥俄州州立大学(OSU)临床和转化科学中心(CCTS)成立于2007年,
我们的愿景是推动今天的发现,以改善所有人的健康。我们雇用了一个全面的
通过教育和职业发展的高度T1-T4科学的全方位解决方法
训练有素的劳动力与强大的CTR资源系统相结合。我们在CTSA中发挥了领导作用
通过共享工具和方法建立联盟,以推进合作减少风险;采用其他中心的创新;以及
全面参与CTSA联盟活动(例如,多中心试验)。我们还支持社区参与
研究解决我们社区中最紧迫的健康问题(例如,阿片类药物危机,COVID-19)。然而,
工作仍然。因此,我们在OSU/NCH和俄亥俄州的社区建立独特的优势。我们有
利用我们在数据科学方面的战略投资、强大的资源环境和充满活力的CTR
社区解决CTS的差距和障碍。我们现在将解决五个CTS障碍,以改善
CTR的质量、效率和严谨性:(1)需要提高效率和有效性,以推进CTR,
确保成果在医疗保健中得到传播和实施; 2)教育和培训创新不
达到完整的CTR劳动力,导致CTS劳动力下降和多样化不足,缺乏
知识和技能,以推进合作减少风险; 3)有限的真实参与,不同的利益相关者在整个
研究生命周期; 4)复杂数据集的增长需要整合临床、环境和
研究数据,需要数据可访问性的民主化,以促进数据公平;以及5)种族不公正,
SDoH,我们组建的CTR团队,以及对我们结果的解释会影响健康差异。应用健康
公平和DEIA框架,我们将追求五个目标:目标1:发展创新,
解决CTR面临的紧迫障碍的方法、途径和工具。目标2:支持培训和
CTS全体员工的职业发展。目标3:吸引学术界和科学界的声音
学科,患者,社区和行业,在科学的整个生命周期中进行CTR和CTS
过程目标4:部署一个可访问的,响应式的和集成的研究资源系统。目标5:
通过降低数据访问和计算资源的进入成本,使信息资源民主化。与
作为对指标驱动决策的承诺,我们将通过应用可再生能源,
AIM框架将为未来7年的战略支点提供信息。这一建议重申了我们的承诺,
推进CTS并扩大我们与利益相关者的接触,以提高严谨性、影响力和相关性
CTR.我们将通过集中的CTS开发、分享和采用创新,以提高社区的CTR
我们服务的人和我们参与的人这些资源、熟练的劳动力和机构优势提供了一个灵活的
基金会将促进对新出现的公共卫生问题作出快速反应,并将确保公平的透镜,
应用于所有CTR,因此没有人会在CTR的进步中落后,以改善人类健康。
英文摘要
ABTRACT
The Ohio State University (OSU) Center for Clinical and Translational Science (CCTS) was formed in 2007,
with the vision to advance today’s discoveries to improve health for all. We employed a comprehensive
approach to address the full spectrum of T1-T4 science via the education and career development of a highly
trained workforce integrated with a robust system of CTR resources. We provided leadership in the CTSA
Consortium through sharing of tools and methods to advance CTR; adopted innovations from other hubs; and
fully engaged in CTSA Consortium activities (e.g., multisite trials). We also supported community engaged
research addressing the most pressing health issues in our communities (e.g., opioid crisis, COVID-19). Yet,
work remains. Thus, we build upon unique strengths at OSU/NCH and in Ohio’s communities. We have
leveraged our strategic investment in data sciences, a robust environment of resources, and a vibrant CTR
community to address CTS gaps and barriers. We will now address five CTS roadblocks to improve the
quality, efficiency, and rigor of CTR: (1) need for improved efficiencies and effectiveness to advance CTR and
ensure results are disseminated and implemented into healthcare; 2) education and training innovations do not
reach the full CTR workforce, resulting in a declining and inadequately diverse CTS workforce, lacking the
knowledge and skills to advance CTR; 3) limited authentic participation by diverse stakeholders across the
research life cycle; 4) growth of complex datasets necessitates integration of clinical, environmental, and
research data, with need for democratization of data accessibility to advance data equity; and 5) racial injustice,
SDoH, the CTR teams we form, and interpretation of our results impact health disparities. Applying a health
equity and DEIA framework to every activity, we will pursue five aims: Aim 1: Develop innovations in
methods, approaches, and tools to address pressing roadblocks facing CTR. Aim 2: Support training and
career development of the full CTS workforce. Aim 3: Engage voices from across academic and scientific
disciplines, patients, communities, and industry to conduct CTR and CTS across the full lifecycle of the scientific
process. Aim 4: Deploy an accessible, responsive, and integrated system of research resources. Aim 5:
Democratize informatics resources by lowering the cost of entry for data access and computing resources. With
a commitment to metric-driven decision-making, we will evaluate the impact of the CCTS by applying the RE-
AIM framework to inform strategic pivots over the next 7 years. This proposal reaffirms our commitment to
advance CTS and expands our engagement with stakeholders to increase rigorous, impactful, and relevant
CTR. We will develop, share, and adopt innovations through focused CTS to enhance CTR for the communities
we serve and those we engage. These resources, skilled workforce, and institutional strengths provide an agile
foundation to facilitate rapid responses to emerging public health issues, and will ensure an equity lens is
applied to all CTR so no one is left behind from the advances of CTR to improve human health.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2196/46309
发表时间:
2023-12-08
期刊:
JOURNAL OF MEDICAL INTERNET RESEARCH
影响因子:
7.4
作者:
[Lee, David, Jiang, Tao, Crocker, Jennifer, Way, Baldwin]
通讯作者:
Way, Baldwin
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
-
批准号:10524167
-
项目类别:
-
资助金额:$6.25万
-
财政年份:2021
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Moderating Role of Sibling Relationships (Diversity Supplement for D. Garcia)
-
批准号:10381330
-
项目类别:
-
资助金额:$3.42万
-
财政年份:2021
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
-
批准号:10348200
-
项目类别:
-
资助金额:$13.48万
-
财政年份:2021
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
-
批准号:10737753
-
项目类别:
-
资助金额:$2.9万
-
财政年份:2021
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
-
批准号:10771642
-
项目类别:
-
资助金额:$2.9万
-
财政年份:2021
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Moderating Role of Residential Location (Diversity Supplement for V. Patterson)
-
批准号:10382011
-
项目类别:
-
资助金额:$3.42万
-
财政年份:2021
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
-
批准号:10524166
-
项目类别:
-
资助金额:$6.25万
-
财政年份:2021
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
-
批准号:10608131
-
项目类别:
-
资助金额:$67.71万
-
财政年份:2021
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Sibling and Parent Bereavement from Childhood Cancer
-
批准号:6973660
-
项目类别:
-
资助金额:$43.87万
-
财政年份:2005
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Sibling and Parent Bereavement from Childhood Cancer
-
批准号:7618250
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2005
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Sibling and Parent Bereavement from Childhood Cancer
-
批准号:7111124
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2005
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Sibling and Parent Bereavement from Childhood Cancer
-
批准号:7417936
-
项目类别:
-
资助金额:$46.48万
-
财政年份:2005
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Sibling and Parent Bereavement from Childhood Cancer
-
批准号:7250281
-
项目类别:
-
资助金额:$44.34万
-
财政年份:2005
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Adjustment of Pediatric Brain Tumor Survivors
-
批准号:6553077
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2002
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
Adjustment of Pediatric Brain Tumor Survivors
-
批准号:6746728
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2002
-
负责人:CYNTHIA A GERHARDT
-
依托单位:
海外基金